Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00415610 · ClinicalTrials.gov registry record · Phase 1

Antihypertensive Treatment in Acute Cerebral Hemorrhage

A Phase 1 study of Hypertension and Stroke, sponsored by University of Minnesota.

Completed
Registry status
Phase 1
Development phase
60
Enrollment target
12
Study locations

NCT00415610 is a Phase 1 study of Hypertension and Stroke that has completed, run by University of Minnesota. The registered enrollment target is 60 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00415610, a Phase 1 study of Hypertension and Stroke, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
Phase 1
Development phase
60 participants
Enrollment target
12
Study locations

Study Summary

The purpose of this trial is to evaluate the safety and effectiveness of lowering blood pressure using nicardipine in persons with acute hypertension associated with intracerebral hemorrhage.

Conditions Studied

Hypertension Stroke Intracerebral Hemorrhage

Interventions

  • DRUG nicardipine

Study Locations (12)

Kansas

  • Kansas University Medical Center - Kansas City
  • The University of Kansas School of Medicine, Wichita Via Christi Regional Medical Center - Kansas City

New Jersey

  • JFK Medical Center - Edison
  • University of Medicine and Dentistry of New Jersey - Newark

Ohio

  • Case Western Reserve University - Cleveland
  • Ohio State University - Columbus

California

  • University of Southern California - Los Angeles

Massachusetts

  • Massachusetts General/Brigham Women's Hospital - Boston

Minnesota

  • Clinical Coordinating Center: University of Minnesota, Fairview Hospital - Minneapolis

Missouri

  • Saint Louis University - St Louis

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2005-07
Est. Completion 2008-03
Phase Phase 1

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00415610

The ClinicalTrials.gov registry entry for NCT00415610 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which nicardipine is the first listed.

NCT00415610 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Kansas, New Jersey, Ohio.

Frequently Asked Questions

What is clinical trial NCT00415610 about?

NCT00415610 is a clinical study titled "Antihypertensive Treatment in Acute Cerebral Hemorrhage". The purpose of this trial is to evaluate the safety and effectiveness of lowering blood pressure using nicardipine in persons with acute hypertension associated with intracerebral hemorrhage.

What is the current status of trial NCT00415610?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2005-07. Estimated completion is 2008-03.

What conditions does trial NCT00415610 study?

This clinical trial studies the following conditions: Hypertension, Stroke, Intracerebral Hemorrhage.

What interventions are being tested in trial NCT00415610?

The interventions under investigation include: nicardipine (DRUG).

Who is sponsoring clinical trial NCT00415610?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00415610 being conducted?

This trial has 12 study locations across California, Kansas, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Stroke

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.